Trexquant Investment’s Maravai LifeSciences MRVI Stock Holding History

Trexquant Investment’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-251,299	Closed	-$2.09M	–	1750
2024 Q3	$2.09M	Sell	251,299 -404,248	-62%	-$3.49M	0.03%	793
2024 Q2	$4.69M	Buy	655,547 +223,998	+52%	+$1.93M	0.07%	424
2024 Q1	$3.74M	Buy	+431,549	New	+$2.92M	0.07%	412
2023 Q2	–	Sell	-108,458	Closed	-$1.52M	–	1660
2023 Q1	$1.52M	Buy	+108,458	New	+$1.56M	0.04%	562
2022 Q2	–	Sell	-23,548	Closed	-$831K	–	1732
2022 Q1	$831K	Sell	23,548 -132,620	-85%	-$4.45M	0.04%	549
2021 Q4	$6.54M	Buy	+156,168	New	+$6.33M	0.4%	41
2021 Q3	–	Sell	-19,511	Closed	-$814K	–	1359
2021 Q2	$814K	Buy	+19,511	New	+$756K	0.07%	356

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Trexquant Investment's MRVI Position: Q4 2024 in Review

Trexquant Investment sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 251,299 shares — an estimated $2.09M sold.

Trexquant Investment first reported a position in MRVI in Q2 2021 and held it in 7 quarters. The position peaked at $6.54M in Q4 2021. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

Trexquant Investment reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
Trexquant Investment sold 251,299 Maravai LifeSciences shares in Q4 2024, an estimated $2.09M.
Trexquant Investment first reported a position in Maravai LifeSciences in Q2 2021 and held it in 7 quarters.
Trexquant Investment's Maravai LifeSciences position peaked at $6.54M in Q4 2021.
185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on Trexquant Investment's 13F filing for Q4 2024, filed 12 Feb 2025.